Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Halaven – Treatment of Metastatic Breast Cancer

The FDA approval of Halaven was based on the results of the phase III clinical trials named EMBRACE.

Go Top